HIV News and Research

RSS

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Tuberculosis (TB) incidence in the UK has declined over the past 4 years, with fewer numbers of new migrants diagnosed with the disease. A new study, published in The Lancet finds that migrants arriving on visas to the UK from countries at high risk of TB and who were pre-screened for TB, pose a negligible risk of onwards infection, despite being at increased risk of developing TB themselves.

13 Oct 2016

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

A team of physicians and laboratory scientists has taken a key step toward a cure for sickle cell disease, using CRISPR-Cas9 gene editing to fix the mutated gene responsible for the disease in stem cells from the blood of affected patients.

12 Oct 2016

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

Mathematical modeling of the brain scans of patients with Alzheimer's disease and others at risk for the devastating neurodegenerative disorder has identified specific patterns of brain atrophy that appear to be related to the loss of particular cognitive abilities.

8 Oct 2016

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

Nearly 1,000 boys in the New York Tri-State area have been diagnosed with Duchenne Muscular Dystrophy (DMD) and, until now, had to travel out of the state for comprehensive care.

7 Oct 2016

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

7 Oct 2016

Study provides important insights into impact of late HIV testing

An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.

7 Oct 2016

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

5 Oct 2016

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Recent work has shown that Zika virus persists in semen for up to 6 months after infection. In a correspondence published in The Lancet Infectious Diseases, the researchers, in addition to confirming its long persistence in semen (in this case for more than 130 days, i.e., over 4 months), reveal the presence of the virus even within spermatozoa.

4 Oct 2016

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

A comprehensive review of studies evaluating strategies for treating certain acute medical conditions without hospital admission finds that all four evaluated strategies appear to be safe, often improve patient and caregiver satisfaction, and reduce health care costs.

4 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

Researchers move one step closer to developing effective universal flu vaccine

Researchers at McMaster University and two American universities have taken another step closer to developing a much more effective, "one-punch" universal flu vaccine.

4 Oct 2016

CCN article outlines unique treatment options for cardiovascular patients with HIV

Cardiovascular disease has become the leading cause of death for those living with HIV, as the infection has moved from a terminal disease to a chronic illness.

3 Oct 2016

New molecular biology technique could help identify virus-fighting potential of existing drugs

A new, computer-based screening method could reveal the virus-fighting potential of drugs originally developed to treat other conditions, reports a study in PLOS Computational Biology.

3 Oct 2016

Special issue of American Journal of Public Health explores impacts of Teen Pregnancy Prevention Program

A new supplement of the American Journal of Public Health out today explores the impacts of the U.S. Department of Health and Human Services' Office of Adolescent Health's Teen Pregnancy Prevention Program. This Journal issue contains expert commentary, research and recommendations based on outcomes from the program's implementation.

30 Sep 2016

Wayne State receives NIH funding to address health issues of HIV-positive and at-risk youth

A team of researchers led by Wayne State University has been awarded funding as a part of the Adolescent Medicine Trials Network for HIV/AIDS Interventions, a research network devoted to the health and well-being of adolescents and young adults with HIV or at risk for HIV infection.

28 Sep 2016

HIV News and Research

Migrants pre-screened for TB pose negligible risk of infection, new study finds

Genome engineering-based methods pave way for new treatment of patients with sickle cell disease

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

Study provides important insights into impact of late HIV testing

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Researchers confirm long persistence of Zika virus in semen and reveal its presence within spermatozoa

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Antibody protection may help control infection caused by TB bacteria

Researchers move one step closer to developing effective universal flu vaccine

CCN article outlines unique treatment options for cardiovascular patients with HIV

New molecular biology technique could help identify virus-fighting potential of existing drugs

Special issue of American Journal of Public Health explores impacts of Teen Pregnancy Prevention Program

Wayne State receives NIH funding to address health issues of HIV-positive and at-risk youth

New project clarifies molecular processes involved in hidden HIV reservoir

Super-Resolution Imaging of Biological Specimens

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News